Tagged with Samsung

South Korea Pharma News: Merck Builds New $326 Million Plant; EuBiologics Gets Cholera Vaccine Prequalification
Top Biologics CDMOs 2023
Samsung Biologics Rides CDMO Expansion Wave with New USD 1.5 Billion Korean Investment
PharmaBoardroom’s 10 Most Read Interviews of 2022
On Track for a Major Share of Global Pharma Manufacturing
Top Global CDMOs 2022
John Rim – CEO, Samsung Biologics
Five Leading Biosimilars Companies 2022
South Korea’s Top COVID-19 Vaccine Companies
Korea Pharma News: Samsung Bioepis Goes Down Under; Blockchain-Based Vaccine Certificates; The First Korean Blockbuster?
China: Green Valley Alzheimer’s Trial; Samsung Biologics Expansion; Fosun Ends COVID-19 Vaccine Development
Company Profile: Samsung Biologics
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here